ARCHIVES

M.D. Anderson Closes Trials following FDA Requests for Data

This article is from The Cancer Letter archive.

Vol. 22 No. 07 | February 16, 1996

Download PDF Visit The Full Archive

Related Articles

Fox Chase Publishes Its Cancer Survival Data

February 4, 2011

Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation

June 29, 2012

NCI, NCAB Consider Moving Basic Science Centers Out Core Grant Pool, Into Research Programs

February 10, 1989

Quality of Care: ASCO Publishes “Top Five” Ways to Improve Cancer Care

November 1, 2013

New Treatment Modalities For Endometrial Cancer

March 26, 2004

House Committee Expands Rauscher Pay Bill, Includes All NIH Directors, Asst. Secretary

July 30, 1976